PAHC

Phibro Animal Health Corporation Healthcare - Drug Manufacturers - Specialty & Generic Investor Relations →

NO
47.1% ABOVE
↑ Moving away Was 35.4% last week
-15% -10% -5% 0% 5% 10% 15%+
Signal Threshold $24.45
14-Week RSI 54
Rel. Volume (14w) This week's trading vs. the 14-week average 1.2x
Buyers vs. Sellers (14w) Are up-weeks or down-weeks getting more volume? 1.03

Phibro Animal Health Corporation (PAHC) closed at $35.97 as of 2026-11-13, trading 47.1% above its 200-week moving average of $24.45. The stock moved further from the line this week, up from 35.4% last week. The 14-week RSI sits at 54, indicating neutral momentum.

Trading volume is running at 1.2x of its 14-week average, which is in the normal range. The balance between buying and selling volume (1.03 ratio) is neutral — neither side is clearly dominating.

Over the past 609 weeks of data, PAHC has crossed below its 200-week moving average 6 times. On average, these episodes lasted 52 weeks. Historically, investors who bought PAHC at the start of these episodes saw an average one-year return of +1.6%.

With a market cap of $1460 million, PAHC is a small-cap stock. Free cash flow yield is currently negative, meaning the company is burning cash. Return on equity stands at 28.2%, indicating strong profitability. The stock trades at 3.5x book value.

Over the past 11.8 years, a hypothetical investment of $100 in PAHC would have grown to $134, compared to $442 for the S&P 500. PAHC has returned 2.5% annualized vs 13.5% for the index, underperforming the broader market over this period.

Free cash flow has been declining. A deteriorating cash flow trend warrants extra scrutiny — the stock may be cheap for a reason.

Business Health

Annual financials — how the underlying business has performed over the past several years.

Cash Flow Free cash flow & net income ($M)

Revenue Annual revenue ($M) — business growth proxy

Total Debt Balance sheet debt ($M)

ROIC Return on invested capital (%)

FCF Yield Free cash flow / market cap (%) — Yartseva signal

Gross Margin Pricing power & competitive moat (%)

Shares Outstanding Buybacks vs dilution (millions)

Growth of $100: PAHC vs S&P 500

Monthly data normalized to $100 at start. Vertical dashed lines mark 200-week MA touches.

What Happens After PAHC Crosses Below the Line?

Across 6 historical episodes, buying PAHC when it crossed below its 200-week moving average produced an average return of +3.3% after 12 months (median +8.0%), compared to +17.3% for the S&P 500 over the same periods. 50% of those episodes were profitable after one year. After 24 months, the average return was +10.5% vs +38.0% for the index.

Each line shows $100 invested at the moment PAHC crossed below its 200-week MA. Bold blue = stock average. Gray dashed = S&P 500 average over same periods.

Bean Score Experimental

The Bean Score measures how far a stock's free cash flow yield has deviated from its own quarterly baseline, normalized by the stock's historical behavior. Between earnings dates, FCF is constant — so the score is purely a function of stock price. The levels below show at what prices PAHC would reach each dislocation threshold.

Current Bean Score +1.25σ
Current FCF Yield 2.85%
Baseline Yield 2.76%
Historical σ 0.12pp

Dislocation Price Levels

Prices where PAHC's Bean Score would hit each σ threshold. Valid until next earnings report: 2027-02-03.

LevelσPriceSignal
Deep Value+2σ$34.88Unusually cheap — analysis point
Value+1σ$36.35Cheap vs. own history
Fair Value+0σ$37.95Historical mean behavior
Expensive-1σ$39.70Expensive vs. own history
Deep Expensive-2σ$41.61Unusually expensive — analysis point

Quarterly FCF & Yield Trailing twelve-month free cash flow and yield at each quarter end

Recent Earnings

DateEPS Est.EPS ActualSurprise
2026-11-04$0.78$0.79+0.9%
2026-08-26$0.73$0.85+17.1%
2026-05-06$0.71$0.76+6.5%
2026-02-04$0.67$0.87+29.9%
Data depth: 2 quarterly baselines, 19 price observations — Limited history (4+ quarters preferred for reliability)

Signal Accuracy Collecting Data

The Bean Score system is accumulating weekly data to validate signal accuracy. After 13+ weeks of history, this section will display win rates and average returns for each σ threshold crossing — answering the question: "When this score says cheap or expensive, does the price subsequently move in the expected direction?"

21 / 13 weeks minimum

the write-ups I read Simply Wall St · Visual company reports and write-ups. Free tier covers five reports a month. referral

Theoretical framework — not backtested or forward-tested. The Bean Score uses trailing twelve-month free cash flow yield as a dislocation identifier. It measures whether the market has pushed a stock's yield unusually far from its own baseline behavior. These levels are analysis points: prices at which the yield deviation becomes unusual enough to justify the work. FCF values update quarterly with earnings; between reports, all movement is price-driven.

Dislocation Scores Experimental

Each score measures deviation from PAHC's own historical baseline — the same idea as the Bean Score, applied to different fundamentals. Positive means cheaper or more dislocated than this stock's norm. Scores marked σ are normalized by the stock's own variability; pp values are simple deltas from its recent baseline.

⚠ Earnings quality deteriorating — net income is outrunning free cash flow vs this company's own norm. Cheapness signals here deserve extra scrutiny.
Yield Dislocation -0.98σ Dividend yield vs own 10-yr norm
Drawdown Score -0.88σ Distance from line vs own history
Sector-Relative -0.82σ Vs sector median this week
Buyback Acceleration +0.0pp YoY share change vs own 3-yr pace (− = accelerating)
Insider Intensity 63th TTM buys / market cap, percentile of buyers
FCF Yield vs History -1.3pp Vs own recent annual mean
Earnings Quality Deteriorating Accrual gap trend (+4.8pp of revenue)

Theoretical framework — not backtested. These scores describe how unusual today's readings are for this specific company. Each one is an analysis point, a reason to open the filings. Annual-statement scores (buyback, accruals, FCF vs history) rest on only ~4 yearly data points and are deltas, not sigmas.

Historical Touches

PAHC has crossed below its 200-week MA 6 times with an average 1-year return of +1.6% after recovery.

Crossed BelowRecoveredWeeksMax Depth1-Year ReturnReturn Since Touch
Feb 2016Sep 20163235.0%+9.7%+58.3%
Oct 2016Nov 201656.5%+43.0%+66.7%
Nov 2016Dec 201610.8%+27.6%+64.9%
Dec 2018Mar 20191411.5%-21.0%+36.2%
May 2019Jun 202110946.6%-22.9%+43.5%
Jun 2021Apr 202414947.5%-27.0%+43.9%
Average52—+1.6%—

Frequently Asked Questions

Is PAHC below its 200-week moving average?

No. Phibro Animal Health Corporation (PAHC) is currently 47.1% above its 200-week moving average of $24.45. It would need to fall to $24.45 to cross below the line.

What is PAHC's 200-week moving average price?

Phibro Animal Health Corporation's 200-week moving average is $24.45 as of 2026-11-13. This is the average weekly closing price over roughly the last 4 years, and it acts as a long-term trend line. When a stock drops below this level, it can signal that the price has fallen far enough from the long-term trend to attract value-oriented investors.

What happens when PAHC drops below its 200-week moving average?

PAHC has crossed below its 200-week moving average 6 times in our data. On average, buying at that moment produced a one-year return of +1.6%. These dips have historically been decent entry points. These episodes lasted 52 weeks on average.

Is PAHC a good value right now?

Here's what our data says about PAHC as of 2026-11-13: The stock is above its 200-week moving average, so it doesn't currently meet our primary signal. The 14-week RSI is 54. Free cash flow is currently negative. Return on equity is 28.2%. Price-to-book is 3.5x. This is not a buy or sell recommendation — always do your own research.

How does PAHC compare to the S&P 500?

Over the past 11.8 years, $100 invested in PAHC would have grown to $134, compared to $442 for the S&P 500. That's 2.5% annualized vs 13.5% for the index. PAHC has underperformed the broader market over this period.

Does PAHC pay a dividend?

Yes. Phibro Animal Health Corporation currently pays a dividend yield of 133.00%.

Not financial advice. This is an educational tool. Past performance does not guarantee future results. Do your own research before making investment decisions.

Data as of week of 2026-11-13